Literature DB >> 24022500

Dual-energy x-ray absorptiometry: interpreting reports and serial measurements.

Sydney L Bonnick1.   

Abstract

Physicians and other health care providers requesting dual-energy x-ray bone density studies must be able to critically review and interpret such studies. This requires an understanding of the computerized result components of the studies and how such data can be applied in clinical practice. The timing and interpretation of serial bone density studies is governed by the concepts of precision and least significant change. These statistical concepts are well within the purview of the practicing physician. Serial bone density studies cannot be interpreted without prior knowledge of the precision and least significant change of the test.

Mesh:

Year:  2013        PMID: 24022500     DOI: 10.1097/GRF.0b013e3182a8240c

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  4 in total

1.  The clinician's guide to prevention and treatment of osteoporosis.

Authors:  M S LeBoff; S L Greenspan; K L Insogna; E M Lewiecki; K G Saag; A J Singer; E S Siris
Journal:  Osteoporos Int       Date:  2022-04-28       Impact factor: 5.071

2.  Comparison of Central and Peripheral Bone Mineral Density Measurements in Postmenopausal Women.

Authors:  Azza M Abdelmohsen
Journal:  J Chiropr Med       Date:  2017-09-20

3.  Clinician's Guide to Prevention and Treatment of Osteoporosis.

Authors:  F Cosman; S J de Beur; M S LeBoff; E M Lewiecki; B Tanner; S Randall; R Lindsay
Journal:  Osteoporos Int       Date:  2014-08-15       Impact factor: 4.507

4.  Protocol for a randomized controlled trial to compare bone-loading exercises with risedronate for preventing bone loss in osteopenic postmenopausal women.

Authors:  Laura D Bilek; Nancy L Waltman; Joan M Lappe; Kevin A Kupzyk; Lynn R Mack; Diane M Cullen; Kris Berg; Meghan Langel; Melissa Meisinger; Ashlee Portelli-Trinidad; Molly Lang
Journal:  BMC Womens Health       Date:  2016-08-30       Impact factor: 2.809

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.